Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition.

Blood
Petra S BachmannRichard B Lock

Abstract

Glucocorticoids play a critical role in the therapy of lymphoid malignancies, including pediatric acute lymphoblastic leukemia (ALL), although the mechanisms underlying cellular resistance remain unclear. We report glucocorticoid resistance attributable to epigenetic silencing of the BIM gene in pediatric ALL biopsies and xenografts established in immune-deficient mice from direct patient explants as well as a therapeutic approach to reverse resistance in vivo. Glucocorticoid resistance in ALL xenografts was consistently associated with failure to up-regulate BIM expression after dexamethasone exposure despite confirmation of a functional glucocorticoid receptor. Although a comprehensive assessment of BIM CpG island methylation revealed no consistent changes, glucocorticoid resistance in xenografts and patient biopsies significantly correlated with decreased histone H3 acetylation. Moreover, the histone deacetylase inhibitor vorinostat relieved BIM repression and exerted synergistic antileukemic efficacy with dexamethasone in vitro and in vivo. These findings provide a novel therapeutic strategy to reverse glucocorticoid resistance and improve outcome for high-risk pediatric ALL.

References

Sep 20, 2002·BioTechniques·Mario F Fraga, Manel Esteller
Aug 29, 2003·The Journal of Steroid Biochemistry and Molecular Biology·M Scott WebbE Brad Thompson
Nov 25, 2003·The New England Journal of Medicine·James G Herman, Stephen B Baylin
Dec 20, 2003·The Journal of Biological Chemistry·Tzippi Hershko, Doron Ginsberg
Apr 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Alexander EgleSuzanne Cory
Oct 19, 2004·Seminars in Cancer Biology·Andrew P Feinberg
Nov 17, 2004·Cell Stress & Chaperones·Tina R Hubler, Jonathan G Scammell
Sep 9, 2006·Blood·Cinta Mestre-EscorihuelaJose A Martinez-Climent
Feb 27, 2007·Cell·Tony Kouzarides
Mar 9, 2007·Nature·Charles G MullighanJames R Downing
Apr 18, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bhupinder S MannRichard Pazdur
May 2, 2007·Proceedings of the National Academy of Sciences of the United States of America·R K LindemannR W Johnstone
Jul 13, 2007·The Journal of Biological Chemistry·Fernando J BarreyroGregory J Gores
Feb 8, 2008·BioTechniques·Filipe V JacintoManel Esteller
Sep 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Deepa BhojwaniUNKNOWN German Cooperative Study Group for Childhood Acute Lymphoblastic Leukemia
Oct 9, 2008·Annual Review of Pathology·Christine A Iacobuzio-Donahue
Dec 11, 2008·Journal of the National Cancer Institute·Nicolas PottierMeyling H Cheok
May 7, 2009·Pediatric Blood & Cancer·Nino KeshelavaMalcolm A Smith
Jun 11, 2009·Molecular Cancer Therapeutics·Leigh EllisRicky W Johnstone
Jul 28, 2009·Annual Review of Medicine·Ramiro GarzonCarlo M Croce

❮ Previous
Next ❯

Citations

Apr 16, 2011·Leukemia·L S SteelmanJ A McCubrey
Dec 21, 2013·Nature Reviews. Molecular Cell Biology·Peter E CzabotarJerry M Adams
Sep 10, 2011·The Journal of Biological Chemistry·Carwyn DaviesRichard B Lock
Jun 8, 2013·ILAR Journal·Shama ViraniLaura S Rozek
Jan 22, 2011·Current Opinion in Hematology·Ross A Okimoto, Richard A Van Etten
Dec 7, 2011·Cancer Discovery·Anthony C FaberJeffrey A Engelman
Dec 6, 2011·PloS One·Vera MagistroniCarlo Gambacorti-Passerini
Aug 4, 2012·Critical Reviews in Eukaryotic Gene Expression·Hisashi Harada, Steven Grant
Apr 26, 2012·Future Medicinal Chemistry·Francesca MusumeciMaurizio Botta
Feb 23, 2013·ISRN Hematology·Ronit Vogt Sionov
Aug 27, 2014·Pharmacogenomics·Elixabet Lopez-LopezAfrica Garcia-Orad
Oct 13, 2015·International Journal of Cancer. Journal International Du Cancer·Belal FirwanaAref Al-Kali
Mar 21, 2012·Expert Opinion on Pharmacotherapy·Maria Florencia TanakaElias Jabbour
Apr 29, 2014·Pharmacology & Therapeutics·Prithviraj BoseSteven Grant
Dec 2, 2015·The Journal of Infectious Diseases·Zhengguo ZhangSudhanshu Bhushan
Oct 13, 2015·Pediatrics International : Official Journal of the Japan Pediatric Society·Hiroaki Goto
Apr 3, 2012·Journal of Cellular Biochemistry·Manuela ManciniMaria Alessandra Santucci
Feb 23, 2012·Pediatric Blood & Cancer·Nobuko HijiyaRobert J Arceci
Jun 19, 2015·Breast Cancer Research : BCR·Sun Hee ParkHanna Y Irie
Jun 15, 2011·Cell Cycle·Won Jun Oh, Estela Jacinto
Jan 30, 2014·Oncoimmunology·Oliver KeppGuido Kroemer
May 27, 2014·Frontiers in Pediatrics·Michael J Burke, Teena Bhatla
Sep 10, 2016·Blood·Naval Daver, Marina Konopleva
Aug 27, 2016·Expert Opinion on Drug Discovery·Sanil BhatiaJulia Hauer

❮ Previous
Next ❯

Related Concepts

Related Feeds

AIDS Malignancies (ASM)

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Vincent GagnéMaja Krajinovic
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Edurne San José-EnerizJose Roman-Gomez
© 2021 Meta ULC. All rights reserved